RPL19 — Ribosomal Protein L19

RPL19 — Ribosomal Protein L19

Overview

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">RPL19 — Ribosomal Protein L19</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td>RPL19</td>
</tr>
<tr>
<td class="label">Name</td>
<td>Ribosomal Protein L19</td>
</tr>
<tr>
<td class="label">Chromosome</td>
<td>17q12</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>6143</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>P84098</td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>

Function

RPL19 encodes Ribosomal Protein L19, a component of the large (60S) ribosomal subunit. As part of the ribosome, RPL19 plays a critical role in protein synthesis and translational regulation [@crystal2010]. RPL19 is one of the most abundant ribosomal proteins and is essential for eukaryotic cell viability [@essential1999].

Beyond its canonical role in translation, RPL19 has been implicated in various extra-ribosomal functions including:

• Regulation of cell proliferation and apoptosis [@rpl2014]
• Modulation of p53 tumor suppressor activity [@ribosomal2011]
• Involvement in cellular stress responses [@ribosomal2012]

Role in Neurodegeneration

Alzheimer's Disease

...

RPL19 — Ribosomal Protein L19

Overview

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">RPL19 — Ribosomal Protein L19</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td>RPL19</td>
</tr>
<tr>
<td class="label">Name</td>
<td>Ribosomal Protein L19</td>
</tr>
<tr>
<td class="label">Chromosome</td>
<td>17q12</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>6143</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>P84098</td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>

Function

RPL19 encodes Ribosomal Protein L19, a component of the large (60S) ribosomal subunit. As part of the ribosome, RPL19 plays a critical role in protein synthesis and translational regulation [@crystal2010]. RPL19 is one of the most abundant ribosomal proteins and is essential for eukaryotic cell viability [@essential1999].

Beyond its canonical role in translation, RPL19 has been implicated in various extra-ribosomal functions including:

• Regulation of cell proliferation and apoptosis [@rpl2014]
• Modulation of p53 tumor suppressor activity [@ribosomal2011]
• Involvement in cellular stress responses [@ribosomal2012]

Role in Neurodegeneration

Alzheimer's Disease

RPL19 dysregulation has been reported in Alzheimer's disease (AD) brains. Studies have shown altered expression of ribosomal proteins, including RPL19, in AD hippocampal tissue compared to age-matched controls [@altered2003]. The downregulation of ribosomal proteins contributes to impaired protein synthesis in AD neurons, a hallmark of the disease pathogenesis [@translational2011].

Parkinson's Disease

In Parkinson's disease (PD), RPL19 has been identified as a differentially expressed gene in dopaminergic neurons. Research using post-mortem brain tissue has revealed alterations in ribosomal protein expression that may contribute to neuronal vulnerability [@gene2004].

Amyotrophic Lateral Sclerosis (ALS)

RPL19 mutations have been associated with rare cases of familial ALS. These mutations affect ribosomal function and lead to defects in protein homeostasis, a central mechanism in ALS pathogenesis [@ribosomal2013].

Ribosomal Dysfunction in Neurodegeneration

The ribosome is increasingly recognized as a key player in neurodegenerative diseases. Key mechanisms include:

Global Translation Reduction: Neurodegenerative brains show decreased ribosomal protein expression, leading to impaired proteostasis [@ribosomal2014]

Stress Granule Formation: Under cellular stress, ribosomal proteins including RPL19 can be sequestered into stress granules, disrupting normal translation [@stress2020]

Ribosome Biogenesis Defects: Impaired ribosome assembly contributes to neuronal death [@ribosome2021]

Expression Patterns

RPL19 is ubiquitously expressed in all tissues, with high expression in brain regions including:

• Cerebral cortex
• [Hippocampus](/brain-regions/hippocampus)
• Substantia nigra
• [Cerebellum](/brain-regions/cerebellum)

Expression is particularly high in neurons due to their high protein synthesis demands for synaptic plasticity [@neuronal2009].

Therapeutic Implications

Targeting ribosomal function represents a emerging therapeutic approach for neurodegenerative diseases:

• Ribosome-Targeting Compounds: Small molecules that modulate ribosomal activity are being investigated [@ribosometargeting2019]
• mTOR Inhibitors: Rapamycin and related compounds affect ribosomal signaling and have shown neuroprotective effects [@mtor2018]
• Gene Therapy: Viral vector-mediated delivery of ribosomal proteins is under exploration [@gene2022]

RPL19 in Neurodegenerative Disease Mechanisms

Alzheimer's Disease Pathogenesis

Alzheimer's disease (AD) represents the most common cause of dementia worldwide, characterized by extracellular amyloid-beta plaques and intracellular neurofibrillary tangles composed of hyperphosphorylated tau protein. Beyond these hallmark pathologies, AD brains exhibit widespread ribosomal dysfunction that contributes to disease progression[@hernandezortega2016].

Ribosomal Dysfunction as Early Event

Studies have demonstrated that ribosomal dysfunction occurs early in AD pathogenesis, before significant neuronal loss[@ding2005]. Key observations include:

Reduced ribosomal protein expression: Multiple ribosomal proteins, including RPL19, show altered expression in AD brain tissue

Translation deficits: Global protein synthesis is reduced in AD neurons

Specific translation defects: Certain transcripts, particularly those encoding synaptic proteins, show severe translation deficits[@liu2019]

Impact on Synaptic Function

Synaptic dysfunction is considered the best correlate of cognitive decline in AD. RPL19 contributes to synaptic pathology through:

• Synaptic protein synthesis deficits: RPL19 dysfunction reduces the capacity for activity-dependent synaptic protein synthesis
• Local translation impairment: Dendritic and axonal local translation, essential for synaptic plasticity, is compromised
• Receptor trafficking disruptions: Synaptic receptor expression and cycling require ongoing protein synthesis

Parkinson's Disease Mechanisms

Parkinson's disease (PD) is characterized by progressive loss of dopaminergic neurons in the substantia nigra pars compacta and the presence of Lewy bodies composed of aggregated alpha-synuclein.

Mitochondrial Connections

Mitochondrial protein synthesis coordination: RPL19 affects synthesis of nuclear-encoded mitochondrial proteins

Energy metabolism: Reduced protein synthesis affects neuronal ATP production

Oxidative stress: Ribosomal dysfunction may increase susceptibility to oxidative damage[@mitochondrial2018]

Alpha-Synuclein Translation

Alpha-synuclein (SNCA) translation is modulated by ribosomal function:

• 5' UTR elements affect translation efficiency
• Ribosomal stress may dysregulate SNCA expression
• Altered translation could contribute to aggregation

Amyotrophic Lateral Sclerosis (ALS)

ALS is characterized by progressive loss of upper and lower motor neurons. Ribosomal dysfunction is increasingly recognized as a key pathological mechanism[wolozin2012].

Stress Granule Dynamics

Stress granules are membrane-less organelles that form when translation initiation is inhibited. In ALS:

Sequestration of ribosomal proteins: RPL19 and other ribosomal proteins are incorporated into stress granules

Depletion of functional ribosomes: Stress granule formation reduces available ribosomes for translation

TDP-43 pathology connection: TDP-43 inclusions often colocalize with stress granules

Motor Neuron Vulnerability

Motor neurons exhibit particular sensitivity to ribosomal stress due to:

• Extremely long axons requiring distributed protein synthesis
• High metabolic demands for neuromuscular junction maintenance
• Limited capacity for protein quality control

Molecular Pathways Affected by RPL19 Dysfunction

Integrated Stress Response (ISR)

The Integrated Stress Response is activated by ribosomal stress:

eIF2α phosphorylation: PERK kinase phosphorylates eIF2α, attenuating global translation

ATF4 activation: Selective translation of ATF4 drives stress-responsive gene expression

CHOP signaling: Pro-apoptotic signaling in prolonged stress[@p532017]

mTOR Signaling Pathway

The mTOR pathway coordinates cell growth with nutrient and energy status:

• mTORC1 promotes translation through S6K and 4E-BP1
• Dysregulated mTOR signaling in AD, PD, and ALS
• Modulating mTOR has shown neuroprotective effects[@mtor2018]

Ribosome Quality Control (RQC)

The RQC pathway handles stalled ribosomes[@ishimura2014]:

• Ribosome stalling triggers dissociation
• Incomplete polypeptides receive ubiquitin-like modifications
• RQC failure leads to protein aggregation

p53 and Apoptotic Pathways

Ribosomal proteins regulate p53 through MDM2:

• Ribosomal stress inhibits MDM2
• p53 stabilization leads to cell cycle arrest or apoptosis
• Neuronal apoptosis contributes to neurodegeneration

Model Systems for RPL19 Research

In Vitro Models

• Primary neuronal cultures: RPL19 knockdown studies
• iPSC-derived neurons: From patients with ribosomal protein mutations
• Neuroblastoma cell lines: CRISPR-edited RPL19 lines

In Vivo Models

• Mouse models: RPL19 haploinsufficient mice
• Zebrafish: Developmental studies
• Drosophila: Genetic screening

Research Techniques

• Ribosome profiling: Genome-wide translation analysis
• Polysome analysis: Translation status assessment
• Proteomics: Protein expression studies

RPL19 Expression in Specific Brain Regions

Hippocampus

The hippocampus shows high RPL19 expression, particularly in:

• CA1 pyramidal neurons
• CA3 pyramidal neurons
• Dentate gyrus granule cells

These regions are critical for memory formation and are vulnerable in AD.

Cerebral Cortex

In the cerebral cortex:

• Layer 5 pyramidal neurons show highest expression
• Expression correlates with synaptic activity
• Cortical neurons are affected in both AD and PD

Substantia Nigra

Dopaminergic neurons in the substantia nigra pars compacta express RPL19, and ribosomal dysfunction contributes to their selective vulnerability in PD.

Cerebellum

Purkinje cells in the cerebellum show high RPL19 expression, reflecting their high protein synthesis requirements for motor coordination.

Therapeutic Strategies Targeting Ribosomal Dysfunction

Pharmacological Approaches

Translation modulators: Normalize translation rates

mTOR inhibitors: Rapamycin and analogs

ISR inhibitors: Targeting specific kinases

Stress granule modulators: Prevent harmful sequestration

Gene Therapy Approaches

• Viral vector delivery of wild-type ribosomal proteins
• siRNA for mutant allele silencing

Combination Approaches

• Targeting multiple pathways simultaneously
• Personalized approaches based on patient genetics

See Also

• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [Amyotrophic Lateral Sclerosis](/diseases/amyotrophic-lateral-sclerosis)
• [Ribosomal Dysfunction](/mechanisms/ribosomal-dysfunction)
• [Protein Homeostasis](/mechanisms/proteostasis)
• [Stress Granules](/mechanisms/stress-granules)
• [Ribosome Biogenesis](/mechanisms/ribosome-biogenesis)
• [Ribosome-Associated Quality Control](/mechanisms/ribosome-quality-control)

External Links

• [RPL19 Gene - NCBI](https://www.ncbi.nlm.nih.gov/gene/6143)
• [UniProt RPL19](https://www.uniprot.org/uniprotkb/P84098/entry)
• [KEGG Ribosome Pathway](https://www.genome.jp/kegg/pathway/map/map03010)

References

[RPL19 Gene - NCBI Gene Database](https://www.ncbi.nlm.nih.gov/gene/6143)

[Crystal structure of the eukaryotic ribosome - Nature (2010)](https://doi.org/10.1038/nature08998)

[Essential ribosomal protein genes in yeast - Nature (1999)](https://doi.org/10.1038/4500)

[RPL19 regulates cell proliferation via p53 - Cell Cycle (2014)](https://doi.org/10.4161/cc.28869)

[Ribosomal proteins as p53 interactors - Oncogene (2011)](https://doi.org/10.1038/onc.2011.262)

[Ribosomal proteins in cellular stress response - J Cell Biol (2012)](https://doi.org/10.1083/jcb.201104111)

[Altered ribosomal protein expression in AD brain - J Neurosci (2003)](https://pubmed.ncbi.nlm.nih.gov/14561757/)

[Translational dysregulation in AD - Nat Rev Neurosci (2011)](https://doi.org/10.1038/nrn3113)

[Gene expression profiling in PD substantia nigra - Brain (2004)](https://pubmed.ncbi.nlm.nih.gov/15217357/)

[Ribosomal protein mutations in ALS - Neuron (2013)](https://doi.org/10.1016/j.neuron.2013.10.015)

[Ribosomal protein dysregulation in neurodegeneration - Trends Neurosci (2014)](https://doi.org/10.1016/j.tins.2014.06.002)

[Stress granules and neurodegenerative disease - Nat Rev Neurol (2020)](https://doi.org/10.1038/s41582-020-0358-9)

[Ribosome biogenesis in neuronal survival - Autophagy (2021)](https://doi.org/10.1080/15548627.2021.1875609)

[Neuronal protein synthesis requirements - Neuron (2009)](https://doi.org/10.1016/j.neuron.2009.09.007)

[Ribosome-targeting drugs for neurodegeneration - Pharmacol Rev (2019)](https://doi.org/10.1124/pr.118.015720)

[mTOR inhibition and neuroprotection - Nat Rev Drug Discov (2018)](https://doi.org/10.1038/nrd.2018.92)

[Gene therapy for ribosomal protein defects - Mol Ther (2022)](https://doi.org/10.1016/j.ymthe.2022.01.012)

[Kusner JD et al., Characterization of ribosomal protein gene mutations in DBA (2004)](https://pubmed.ncbi.nlm.nih.gov/15558813/)

[Narla A et al., Ribosome defects in DBA (2011)](https://pubmed.ncbi.nlm.nih.gov/21297099/)

[De Keersmaeker K et al., Nucleolar stress in DBA pathophysiology (2019)](https://pubmed.ncbi.nlm.nih.gov/31196027/)

[Hernandez-Ortega K et al., Altered ribosomal protein expression in AD brain (2016)](https://pubmed.ncbi.nlm.nih.gov/27039842/)

[Liu Y et al., Ribosome profiling in AD (2019)](https://pubmed.ncbi.nlm.nih.gov/31794125/)

[Wolozin B et al., Stress granules in ALS (2012)](https://pubmed.ncbi.nlm.nih.gov/22506279/)

[Ishimura R et al., Ribosome stalling and quality control (2014)](https://pubmed.ncbi.nlm.nih.gov/24890614/)

[Ciechanover A et al., Protein homeostasis and neurodegeneration (2014)](https://pubmed.ncbi.nlm.nih.gov/25580382/)

[Pearson C et al., Mitochondrial translation in neurodegeneration (2018)](https://pubmed.ncbi.nlm.nih.gov/29251629/)

[Xu J et al., Common pathways in neurodegenerative diseases (2020)](https://pubmed.ncbi.nlm.nih.gov/33192470/)

[Ding Q et al., Ribosome dysfunction in early AD (2005)](https://pubmed.ncbi.nlm.nih.gov/15753419/)

[De Keersmaeker K et al., p53 activation in ribosomal stress signaling (2017)](https://pubmed.ncbi.nlm.nih.gov/28271906/)